Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Appointed director
Quarterly results
|
|
PORTOLA PHARMACEUTICALS INC (PTLA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/09/2020 |
SC 13G/A
| WELLINGTON MANAGEMENT GROUP LLP reports a 0.8% stake in Portola Pharmaceuticals, Inc. |
| 06/08/2020 |
SC 13G/A
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC reports a 0% stake in Portola Pharmaceuticals Inc |
| 04/09/2020 |
SC 13G/A
| Temasek Holdings Ltd reports a 4.9% stake in Portola Pharmaceuticals, Inc. |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/07/2020 |
SC 13G/A
| Temasek Holdings Ltd reports a 6.2% stake in Portola Pharmaceuticals, Inc. |
| 02/05/2020 |
SC 13G/A
| BlackRock Inc. reports a 8% stake in PORTOLA PHARMACEUTICALS INC |
| 01/08/2020 |
SC 13G/A
| WELLINGTON MANAGEMENT GROUP LLP reports a 13.4% stake in Portola Pharmaceuticals, Inc. |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2019 |
SC 13G/A
| WELLINGTON MANAGEMENT GROUP LLP reports a 13.7% stake in Portola Pharmaceuticals, Inc. |
| 02/06/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2018 |
SC 13G/A
| Flynn James E reports a 0.5% stake in Portola Pharmaceuticals, Inc. |
| 02/13/2018 |
SC 13G/A
| FMR LLC reports a 6.5% stake in PORTOLA PHARMACEUTICALS INC |
| 02/12/2018 |
SC 13G/A
| Temasek Holdings Ltd reports a 7.5% stake in Portola Pharmaceuticals, Inc. |
| 02/12/2018 |
SC 13G/A
| WELLINGTON MANAGEMENT GROUP LLP reports a 12.1% stake in Portola Pharmaceuticals, Inc. |
| 02/08/2018 |
SC 13G/A
| WELLINGTON MANAGEMENT GROUP LLP reports a 9.2% stake in Portola Pharmaceuticals, Inc. |
| 01/29/2018 |
SC 13G/A
| BlackRock Inc. reports a 7.2% stake in PORTOLA PHARMACEUTICALS INC |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/10/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/10/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/09/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 01/25/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 09/12/2016 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 04/11/2016 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
|
|